23 documents found, page 1 of 3

Training in Transcranial Magnetic Stimulation: Experience from a Clinical and R...

Psychedelic treatments for mental health conditions pose challenges for informe...

Interhemispheric imbalance in mood disorders

Mood disorders are very common and disabling conditions worldwide. Classically, two poles have been described in mood disorders spectrum, namely depression and mania. While depression is characterized by negative mood, such as sadness and anhedonia, mania is associated with positive affect, including euphoria and increased energy. When recurrent periods of depression are the sole manifestation of a mood disorde...

Psychedelic treatments for mental health conditions pose challenges for informe...

In past years, clinical trials with psychedelic substances have been conducted to find alternative treatments for hard-to-treat mental health conditions such as treatment-resistant depression, cancer-related depression and anxiety symptoms and post-traumatic stress disorder. Clinical research has advanced under the regulation of national ethical and medication authorities for clinical trials, much as for any st...

Striatal dopamine D2-like receptors availability in obesity and its modulation ...

There is significant evidence linking a 'reward deficiency syndrome' (RDS), comprising decreased availability of striatal dopamine D2-like receptors (DD2lR) and addiction-like behaviors underlying substance use disorders and obesity. Regarding obesity, a systematic review of the literature with a meta-analysis of such data is lacking. Following a systematic review of the literature, we performed random-effects ...

Translation and validation of the Clinician Administered PTSD Scale (CAPS-CA-5)...

Introduction: The aim of this study was to translate and validate into European Portuguese the CAPS-CA-5 (Clinician Administered PTSD Scale for Children and Adolescents), a semi-structured scale for the diagnosis of post-traumatic stress disorder in children and adolescents, according to the DSM-5 criteria. Material and Methods: This study was developed in three stages. In the first stage, the translation and b...

Hemispheric asymmetry of motor cortex excitability in mood disorders – Evidence...

Funding Information: Funding: GC was supported by Fundação para a Ciência e Tecnologia (FCT) through a PhD Scholarship (SFRH/BD/130210/2017). AJO-M is supported by grant FCT-PTDC/MEC-PSQ/30302/2017-IC&DT-LIS BOA-01-0145-FEDER, funded by national funds from FCT/MCTES and co-funded by FEDER, under the Partnership Agreement Lisboa 2020 - Programa Operacional Regional de Lisboa. GC and AJO-M are supported by grant ...

Development of a Checklist of Potentially Traumatic Events in Children and Adol...

Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. G.C. was supported by Fundação para a Ciência e Tecnologia (FCT) through a PhD Scholarship (SFRH/BD/130210/2017); also by grant FCT-PTDC/MED-NEU/31331/2017, funded by FCT/MCTES.; Introduction: Since exposure to potentially traumatic events during childhood and adolesc...

An Argument in Favor of Deep Brain Stimulation for Uncommon Movement Disorders

Funding Information: AJO-M was national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd. (2019–2020), is recipient of a grant from Schuhfried GmbH for norming and validation of cognitive tests, and is national coordinator for Portugal of trials of psilocybin therapy for treatment-r...

In Older Adults the Antidepressant Effect of Repetitive Transcranial Magnetic S...

Funding Information: AJO-M was the national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019–2020), is the recipient of a grant from Schuhfried GmBH for norming and validation of cognitive tests, and is the national coordinator for Portugal of trials of psilocybin therapy for ...